The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis
Posted on: 13 January, 2020
Issue: Vol 20 No 1, January 2020 - March 2020
Related to Immunisation Infectious conditions Population Infants and young children Research States and Territories Northern Territory
Issue: Vol 20 No 1, January 2020 - March 2020
Related to Immunisation Infectious conditions Population Infants and young children Research States and Territories Northern Territory
Middleton BF, Jones MA, Waddington CS, Danchin M, McCallum C, Gallagher S, Leach AJ, Andrews R, Kirkwood C, Cunliffe N, Carapetis J, Marsh JA, Snelling T (2019)
The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis
BMJ Open; 9: e032549
Retrieved from http://dx.doi.org/10.1136/bmjopen-2019-032549